Literature DB >> 9790419

Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans.

C M Shih1, C C Wang.   

Abstract

We report the ability of azithromycin in combination with quinine to eliminate the Babesia infection in a native Taiwanese woman. Failure of elimination of the babesial infection was observed two weeks after treating with standard regimen of oral quinine plus intravenous clindamycin for a 10-day course of therapy. Azithromycin in place of clindamycin was administered for another 10-day course of therapy two months following initial treatment. Clearance of Babesia parasites was observed and verified by hamster inoculation. These results suggest that azithromycin plus quinine should be considered as an alternative therapy for human babesiosis, especially in the failure of treatment with standard regimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790419     DOI: 10.4269/ajtmh.1998.59.509

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

Review 1.  Antiparasitic agent atovaquone.

Authors:  Aaron L Baggish; David R Hill
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Diagnosis and management of human babesiosis.

Authors:  Subhash Chandra Parija; Dinoop Kp; Hrudya Venugopal
Journal:  Trop Parasitol       Date:  2015 Jul-Dec

3.  Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone.

Authors:  Lauren A Lawres; Aprajita Garg; Vidya Kumar; Igor Bruzual; Isaac P Forquer; Isaline Renard; Azan Z Virji; Pierre Boulard; Eduardo X Rodriguez; Alexander J Allen; Sovitj Pou; Keith W Wegmann; Rolf W Winter; Aaron Nilsen; Jialing Mao; Douglas A Preston; Alexia A Belperron; Linda K Bockenstedt; David J Hinrichs; Michael K Riscoe; J Stone Doggett; Choukri Ben Mamoun
Journal:  J Exp Med       Date:  2016-06-06       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.